During the 15th Annual Healthcare Industry Leadership Virtual Conference, A&M experts discussed how COVID-19 has propelled the biotech and pharmaceutical industry – vaccine production, research and innovation and opportunities for investment – tenfold in just a few short months.
In this session, the panelists also discussed:
- Near- and long-term industry outlook
- Expanded patient access for clinical trials
- Developing regulatory challenges
- Emerging players and platforms
- Expanding role for telehealth
Panel Moderator:
Dr. Keith Ghezzi, Managing Director, A&M Healthcare Industry Group
Speakers:
Jacques Mulder, former Managing Director, A&M Healthcare Industry Group
Peter Urbanowicz, Managing Director and Co-Head of A&M's Healthcare Industry Group
Watch the other panel sessions here:
Healthcare Systems in the COVID-19 Era
Diversity & Inclusion in Healthcare Organizations
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Alvarez & Marsal's Healthcare Industry Group Appoints Roger Weems as a Managing Director
June 4, 2025
A&M welcomes Roger Weems as a Managing Director in its Healthcare Industry Group within its Health Systems Practice. Mr. Weems' joining advances their firm's ability to support hospitals and health systems with large scale, operational and financial transformation.
